1. Do you consider this paper is hotspots or important areas in the research field related to neural regeneration? Yes 2. Which area do you think this paper falls into? Neurorepair, neuroprotection, neuroregeneration or neuroplasticity. The subject addressed in this article is worthy of investigation.
The information presented was new.
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The conclusions were supported by the data.
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COMMENTS TO AUTHORS
Strengths:
-This work reported that intrathecal injections of WJ-MSC in 43 patients with ALS have a low incidence of SAE and well tolerability. Based on these claims, it is possible that the careful intrathecal administration of WJ-MSC alone (or in combination with the current drug therapies) could represent a promising new therapeutic approach to extend the life expectancy of patients with ALS.
Weaknesses:
-The work presented in this manuscript seems to only represent the initial stages of a larger clinical study.
The aim of this study is to assess the safety of intrathecal injections of Wharton's Jelly-derived mesenchymal stem cells in 53 recruited patients with amyotrophic lateral sclerosis (ALS). The authors reported no serious adverse effects during the clinical trial and the use of derived mesenchymal stems cells was well-tolerated among patients with ALS.
However, some concerns about this study need to be explained before this manuscript can be considered for -2 - 6-In results section, page 4, line 51-53: The authors may describe the incidence of side effects as % of the total population (as stated in the discussion section for similar studies, page 6, line 9-11).
7-In the discussion section, page 6: The authors mentioned that the safety of intrathecal injection WJ-MSC in ALS patients has been tested by other groups (Sharma et al 2015 & Petrou et al 2016 . Based in the extremely low incidence of serious adverse events (SAE) reported by this work, please explain in this section the differences between the author's technical approach (including molecular techniques to isolate the MSC material) and the work carried out by other scientific groups to explain such SAE differences.
8-In the discussion section: Please briefly state the potential, complications limitations or disadvantaged of the use of intrathecal injections of WJ-MSC in ALS and if the authors have any imaging protocol in place (CT or MRI) to assess any potential complications by the intrathecal delivery approach (hemorrhage, infections, etc.).
